Mice Model Market Is Extrapolated to Reach a Value of $2.7 Billion at a Growing CAGR of 13.9% by 2028
In April 2019, Charles River acquired Citoxlab to strengthen its portfolio & geographic footprint, enhancing the ability to partner with clients across the drug discovery and development continuum. This acquisition helped Charles River strengthen its position in regulated safety assessment services, non-regulated discovery services, animal research models, and medical device testing.
View full press release